Physician profile
Michael Summers
NPI 1891719324
$444.75
in general payments reported to CMS, 2019-2025
14 companies · $78.62 in 2025
The $78.62 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $328 · 2024: $37.81 · 2025: $78.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $444.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $70.03 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $57.72 | 2023-2025 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $56.58 | 2023 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $41.95 | 2023 | |
| Abbvie INC. | $31.34 | 2023 | Vraylar |
| Glaxosmithkline, LLC. | $30.19 | 2023 | Bexsero, Pediarix, Shingrix |
| Alkermes, INC. | $26.01 | 2023 | Aristada, Lybalvi |
| Lilly USA, LLC | $24.38 | 2023 | Mounjaro, Trulicity |
| Neurocrine Biosciences, INC. | $24.27 | 2023 | |
| Pfizer INC. | $19.00 | 2025 | |
| Cranial Technologies, INC | $18.82 | 2023 | Doc Band |
| Teva Pharmaceuticals USA, INC. | $18.00 | 2023 | Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $16.27 | 2024 | Breztri |
| Corium, LLC | $10.19 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Summers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.